glp-1 agonist fda approval Trends in the Development of Receptor Agonists Live Updates on Semaglutide's Current

Values correspond to the minimum and maximum values reported when considering all the studies of the program

Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease

While PPIs are highly effective, appropriate indication and duration of therapy are crucial to minimize potential adverse effects

some are mimics of natural GLP-1 but are resistant to the DPP-4 enzyme, while others are animal-derived and are very close to the human molecule

SBP reduction was mostly mediated by weight loss (7794%) in SURPASS-1, -2 and -3, while mechanisms independent from weight loss accounted for most of the tirzepatide benefit on SBP in SURPASS-4 and -5 (57 and 73%, respectively) [77]

GLP-1 receptor: a new target for sepsis